An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

NCT00784875 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

643

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Insomnia
Secondary Insomnia

Interventions

DRUG: LY2624803
DRUG: LY2624803
DRUG: Placebo
DRUG: zolpidem

Sponsor

Eli Lilly and Company